198 related articles for article (PubMed ID: 17573495)
1. Is pulmonary arterial hypertension in neurofibromatosis type 1 secondary to a plexogenic arteriopathy?
Stewart DR; Cogan JD; Kramer MR; Miller WT; Christiansen LE; Pauciulo MW; Messiaen LM; Tu GS; Thompson WH; Pyeritz RE; Ryu JH; Nichols WC; Kodama M; Meyrick BO; Ross DJ
Chest; 2007 Sep; 132(3):798-808. PubMed ID: 17573495
[TBL] [Abstract][Full Text] [Related]
2. Type 1 neurofibromatosis complicated by pulmonary artery hypertension: a case report.
Simeoni S; Puccetti A; Chilosi M; Tinazzi E; Prati D; Corrocher R; Lunardi C
J Med Invest; 2007 Aug; 54(3-4):354-8. PubMed ID: 17878687
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary hypertension in patients with neurofibromatosis type I.
Montani D; Coulet F; Girerd B; Eyries M; Bergot E; Mal H; Biondi G; Dromer C; Hugues T; Marquette C; O'Connell C; O'Callaghan DS; Savale L; Jaïs X; Dorfmüller P; Begueret H; Bertoletti L; Sitbon O; Bellanné-Chantelot C; Zalcman G; Simonneau G; Humbert M; Soubrier F
Medicine (Baltimore); 2011 May; 90(3):201-211. PubMed ID: 21512413
[TBL] [Abstract][Full Text] [Related]
4. Loss of bone morphogenetic protein receptor 2 is associated with abnormal DNA repair in pulmonary arterial hypertension.
Li M; Vattulainen S; Aho J; Orcholski M; Rojas V; Yuan K; Helenius M; Taimen P; Myllykangas S; De Jesus Perez V; Koskenvuo JW; Alastalo TP
Am J Respir Cell Mol Biol; 2014 Jun; 50(6):1118-28. PubMed ID: 24433082
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcomes of pulmonary arterial hypertension in carriers of BMPR2 mutation.
Sztrymf B; Coulet F; Girerd B; Yaici A; Jais X; Sitbon O; Montani D; Souza R; Simonneau G; Soubrier F; Humbert M
Am J Respir Crit Care Med; 2008 Jun; 177(12):1377-83. PubMed ID: 18356561
[TBL] [Abstract][Full Text] [Related]
6. Investigation of second genetic hits at the BMPR2 locus as a modulator of disease progression in familial pulmonary arterial hypertension.
Machado RD; James V; Southwood M; Harrison RE; Atkinson C; Stewart S; Morrell NW; Trembath RC; Aldred MA
Circulation; 2005 Feb; 111(5):607-13. PubMed ID: 15699281
[TBL] [Abstract][Full Text] [Related]
7. BMPR2 mutations influence phenotype more obviously in male patients with pulmonary arterial hypertension.
Liu D; Wu WH; Mao YM; Yuan P; Zhang R; Ju FL; Jing ZC
Circ Cardiovasc Genet; 2012 Oct; 5(5):511-8. PubMed ID: 22923421
[TBL] [Abstract][Full Text] [Related]
8. Receptor for activated C-kinase 1, a novel interaction partner of type II bone morphogenetic protein receptor, regulates smooth muscle cell proliferation in pulmonary arterial hypertension.
Zakrzewicz A; Hecker M; Marsh LM; Kwapiszewska G; Nejman B; Long L; Seeger W; Schermuly RT; Morrell NW; Morty RE; Eickelberg O
Circulation; 2007 Jun; 115(23):2957-68. PubMed ID: 17515463
[TBL] [Abstract][Full Text] [Related]
9. Clinical and genetic characteristics of pulmonary arterial hypertension in Lebanon.
Abou Hassan OK; Haidar W; Nemer G; Skouri H; Haddad F; BouAkl I
BMC Med Genet; 2018 May; 19(1):89. PubMed ID: 29843651
[TBL] [Abstract][Full Text] [Related]
10. Stress Doppler echocardiography in relatives of patients with idiopathic and familial pulmonary arterial hypertension: results of a multicenter European analysis of pulmonary artery pressure response to exercise and hypoxia.
Grünig E; Weissmann S; Ehlken N; Fijalkowska A; Fischer C; Fourme T; Galié N; Ghofrani A; Harrison RE; Huez S; Humbert M; Janssen B; Kober J; Koehler R; Machado RD; Mereles D; Naeije R; Olschewski H; Provencher S; Reichenberger F; Retailleau K; Rocchi G; Simonneau G; Torbicki A; Trembath R; Seeger W
Circulation; 2009 Apr; 119(13):1747-57. PubMed ID: 19307479
[TBL] [Abstract][Full Text] [Related]
11. Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension.
Machado RD; Aldred MA; James V; Harrison RE; Patel B; Schwalbe EC; Gruenig E; Janssen B; Koehler R; Seeger W; Eickelberg O; Olschewski H; Elliott CG; Glissmeyer E; Carlquist J; Kim M; Torbicki A; Fijalkowska A; Szewczyk G; Parma J; Abramowicz MJ; Galie N; Morisaki H; Kyotani S; Nakanishi N; Morisaki T; Humbert M; Simonneau G; Sitbon O; Soubrier F; Coulet F; Morrell NW; Trembath RC
Hum Mutat; 2006 Feb; 27(2):121-32. PubMed ID: 16429395
[TBL] [Abstract][Full Text] [Related]
12. Endothelin-Bone morphogenetic protein type 2 receptor interaction induces pulmonary artery smooth muscle cell hyperplasia in pulmonary arterial hypertension.
Maruyama H; Dewachter C; Belhaj A; Rondelet B; Sakai S; Remmelink M; Vachiery JL; Naeije R; Dewachter L
J Heart Lung Transplant; 2015 Mar; 34(3):468-78. PubMed ID: 25447587
[TBL] [Abstract][Full Text] [Related]
13. NF1 mutations in neurofibromatosis 1 patients with plexiform neurofibromas.
Kluwe L; Friedrich RE; Korf B; Fahsold R; Mautner VF
Hum Mutat; 2002 Mar; 19(3):309. PubMed ID: 11857752
[TBL] [Abstract][Full Text] [Related]
14. Phenotype and Outcomes of Pulmonary Hypertension Associated with Neurofibromatosis Type 1.
Jutant EM; Jaïs X; Girerd B; Savale L; Ghigna MR; Perros F; Mignard X; Jevnikar M; Bourlier D; Prevot G; Tromeur C; Bauer F; Bergot E; Dauphin C; Favrolt N; Traclet J; Soumagne T; De Groote P; Chabanne C; Magro P; Bertoletti L; Gueffet JP; Chaouat A; Goupil F; Moceri P; Borie R; Fadel E; Wolkenstein P; Brillet PY; Simonneau G; Sitbon O; Humbert M; Montani D
Am J Respir Crit Care Med; 2020 Sep; 202(6):843-852. PubMed ID: 32437637
[No Abstract] [Full Text] [Related]
15. Impaired bone morphogenetic protein receptor II signaling in a transforming growth factor-β-dependent mouse model of pulmonary hypertension and in systemic sclerosis.
Gilbane AJ; Derrett-Smith E; Trinder SL; Good RB; Pearce A; Denton CP; Holmes AM
Am J Respir Crit Care Med; 2015 Mar; 191(6):665-77. PubMed ID: 25606692
[TBL] [Abstract][Full Text] [Related]
16. Imaging Features in
Zhao Q; Zhang R; Shi J; Xie H; Zhang L; Li F; Jiang R; Wu W; Luo C; Qiu H; Li H; He J; Yuan P; Liu J; Gong S; Wang L
Radiology; 2023 Jun; 307(5):e222488. PubMed ID: 37191488
[TBL] [Abstract][Full Text] [Related]
17. Idiopathic pulmonary hypertension: what did we learn from genes?
Sztrymf B; Yaïci A; Jaïs X; Sitbon O; Simonneau G; Humbert M
Sarcoidosis Vasc Diffuse Lung Dis; 2005 Dec; 22 Suppl 1():S91-100. PubMed ID: 16457021
[TBL] [Abstract][Full Text] [Related]
18. Type 1 neurofibromatosis complicated by pulmonary arterial hypertension: A case report.
Küçük M; Öncel CR; Uçar M; Yıldırım AB
Turk Kardiyol Dern Ars; 2017 Jul; 45(5):458-461. PubMed ID: 28694401
[TBL] [Abstract][Full Text] [Related]
19. Relationship of BMPR2 mutations to vasoreactivity in pulmonary arterial hypertension.
Elliott CG; Glissmeyer EW; Havlena GT; Carlquist J; McKinney JT; Rich S; McGoon MD; Scholand MB; Kim M; Jensen RL; Schmidt JW; Ward K
Circulation; 2006 May; 113(21):2509-15. PubMed ID: 16717148
[TBL] [Abstract][Full Text] [Related]
20. [Bone morphogenetic protein type II receptor gene promoter mutation-142G > A in a patient with familial pulmonary arterial hypertension].
Li W; Hu H
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(4):230-4. PubMed ID: 19552837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
